Criteria for 5 years survival prognosis in patients with thymus tumors

Cover Page

Cite item

Full Text

Abstract

Thymoma is a rare tumor of mediastinum, which incidence is less than 1% of all oncological diseases, and 10-20% of primary mediastinum lesions. Current WHO classification (Masaoka staging and histological tumor type) does not allow to determine the necessity for additional methods of treatment and to predict the further development of disease.
The developed individual prognostic system for disease progression probability assessment, based on certain criteria, is a simple and cheap prognostic method in patients with thymoma.

About the authors

P G Kolesnikov

Russian Scientific Center of Roentgenoradiology (RSCRR)

Email: kolesnikov_p_g@bk.ru <mailto:kolesnikov_p_g@bk.ru>
Russian Scientific Center of Roentgenoradiology (RSCRR)

S V Goncharov

Russian Scientific Center of Roentgenoradiology (RSCRR)

Email: kolesnikov_p_g@bk.ru <mailto:kolesnikov_p_g@bk.ru>
Russian Scientific Center of Roentgenoradiology (RSCRR)

O A Yadikov

Moscow cancerregister

Email: kolesnikov_p_g@bk.ru <mailto:kolesnikov_p_g@bk.ru>
Moscow cancerregister

V D Chkhikvadze

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Колесников П.Г., Гончаров С.В., Ядиков О.А., Чхиквадзе В.Д.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.